https://www.selleckchem.com/pr....oducts/gsk2636771.ht
Introduction Lupus nephritis (LN) has a considerable impact on the morbidity and mortality of systemic lupus erythematosus (SLE) patients. Long-term comparative outcome data from the Indian subcontinent on treatment regimens with cyclophosphamide (CYP) and mycophenolate mofetil (MMF) are sparse. We assessed renal and patient survival for these patients in terms of the types of induction - CYP or MMF - and the two maintenance therapies - MMF or azathioprine (AZA). Methods We retrospectively analysed outcomes of 100 LN patients, 67 tre
Мне нравится
Комментарий
Перепост
